NEW YORK (GenomeWeb News) – Manchester, UK-based Tepnel Life Sciences today said that the Illinois Department of Public Health has selected its Elucigene CF-US test for two-stage testing of cystic fibrosis under a newly mandated screening program for all newborns in the state.
 
Tepnel’s test is designed for use on high-throughput capillary sequencers and detects 44 mutations in the cystic fibrosis transmembrane conductance regulator gene and their wild-type counterparts.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The partially reinstated US travel ban leaves space for uncertainty for researchers, Nature News says.

Researchers find a number of traits differ by sex and could affect mouse model studies, according to Reuters.

Tweaking the skin microbiome could help address some skin conditions, the New York Times reports.

In PNAS this week: DNA methylation profiles of tumor tissue, gene dynamics in prokaryotes, and more.